Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells

Molecular Carcinogenesis

Volumn 48, Issue 10, 2009, Pages 953-964

  Chul, Jang Kim ^a   Nishi, Kayoko ^b   Isono, Takahiro ^c   Okuyama, Yusuke ^c   Tambe, Yukihiro ^c   Okada, Yusaku ^c   Inoue, Hirokazu ^c  

^a Kohka Public Hospital   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Alternative splicing; Bladder cancer; Cell invasiveness; Cyclin D1

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CCND1 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; ISOPROTEIN; MESSENGER RNA; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER CELL CULTURE; CANCER INVASION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; BLADDER TUMOR; CELL CYCLE; CELL FRACTIONATION; CELL NUCLEUS; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN ISOFORMS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 70349912696     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20547     Document Type: Article

References (25)

1. Proctor AJ, Coombs LM, Cairns JP, Knowles MA. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene 1991;6:789-795.
2. Lee CC, Yamamoto S, Morimura K, et al. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathological features. Cancer 1997;79:780-789. (Pubitemid 27076344)
3. Shin KY, Kong G, Kim WS, Lee TY, Woo YN, Lee JD. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br J Cancer 1997;75:1788-1792. (Pubitemid 27230705)
4. Suwa Y, Takano Y, Iki M, et al. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder. J Urol 1998;160:897-900. (Pubitemid 29479551)
5. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996;68:67-108. (Pubitemid 26099813)
6. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002;1:226-231.
7. Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993;7:1559-1571. (Pubitemid 23234349)
8. Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000;14:3102-3114. (Pubitemid 32015129)
9. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: Polymorphism, aberrant splicing and cancer risk. Oncogene 2006;25:1620-1628.
10. Hosokawa Y, Gadd M, Smith AP, Koerner FC, Schmidt EV, Arnold A. Cyclin D1 (PRAD1) alternative transcript b: Full-length cDNA cloning and expression in breast cancers. Cancer Lett 1997;113:123-130. (Pubitemid 27113238)
11. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is nuclear oncogene. Cancer Res 2003;63:7056-7061. (Pubitemid 37413439)
12. Solomon DA, Wang Y, Fox SR, et al. Cyclin D1 spliced variants: Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003;278:30339-30347. (Pubitemid 36962428)
13. Burd CJ, Petre CE, Morey LM, et al. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Proc Natl Acad Sci USA 2006;103:2190-2195.
14. Krieger S, Gauduchon J, Roussel M, Troussard X, Sola B. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma. BMC Cancer 2006;6:238. (Pubitemid 44608248)
15. Marzec M, Kasprzycka M, Lai R, et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 2006;108:1744-1750. (Pubitemid 44316145)
16. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998;12:3499-3511. (Pubitemid 28553242)
17. Holley SL, Heighway J, Hoban PR. Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differences. Int J Cancer 2005;114:364-370. (Pubitemid 40279955)
18. Sanchez G, Bittencourt D, Laud K, et al. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic splice isoform in cancer. Proc Natl Acad Sci USA 2008;105:6004-6009. (Pubitemid 351758389)
19. Hoglund M. On the origin of syn- and metachronous urothelial carcinomas. Eur Urol 2007;51:1185-1193. (Pubitemid 46436302)
20. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997;11:957-972. (Pubitemid 27199876)
21. Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008;27:1231-1242.
22. Benzeno S, Lu F, Guo M, et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006;25:6291-6303. (Pubitemid 44564745)
23. Leveque C, Marsaud V, Renoir JM, Sola B. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes. Exp Cell Res 2007;313:2719-2729. (Pubitemid 46977340)
24. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005;24:2796-2809. (Pubitemid 40638091)
25. Li Z, Wang C, Jiao X, et al. Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration. J Biol Chem 2008;283:7007-7015.